Delivery Order SPE2DB20D3505-SPE2DB24FT9B1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.13 firm fixed-price delivery order is for the supply of Bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 150 mg Bupropion HCL XL tablets, a generic medication used for the treatment of depression. The award has a ceiling value of $1,160.61 and a completion date of December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a generic pharmaceutical product used to treat depression and other conditions. The contract has a ceiling value of $60,554.02 and is structured as a Firm Fixed Price delivery order, with a period of performance ending on April 30, 2024. This contract award...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,304.38 firm fixed-price contract is for the supply of Bupropion HCL XL 150 mg tablets, a generic drug used to treat depression and other conditions. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,688.03, is for the delivery of Bupropion HCL XL 300 mg tablets, a generic medication used to treat depression and nicotine addiction. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support...
- This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets, which are prescribed for the treatment of depression and other mental health conditions. The contract, valued at $3,837.38, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999 and running through...
- This federal contract award, valued at $30,713.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 500-count bupropion HCL XL 300 mg tablets, a medication used to treat depression and other conditions. The contract has a completion date of February 7, 2024 and is a firm fixed-price delivery order. No set-aside designation was applied. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $35,290.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 150 mg tablets, a medication used to treat depression and to help people quit smoking. The contract is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $84,078.53 with a firm fixed price and an ultimate completion date of January 25, 2024. The contract is for the supply of Bupropion HCL XL 150 mg tablets, a generic medication used to treat depression and anxiety disorders. The award is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,487.12 firm fixed-price delivery order is for the supply of 4,567,379,185 units of Bupropion HCL XL 300 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT9B1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,069.41 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCL XL 150 mg tablets, a medication used for the treatment of depression and other mental health conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/13/24 |